Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review by GlobalData

VIEWS: 23 PAGES: 27

More Info
									                        Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review
        Reference Code: GDPH28215SA                                                                                                                          Publication Date: DEC 2013



       Table of Contents
       Table of Contents ............................................................................................................................................................................... 1
          List of Tables .................................................................................................................................................................................. 2
          List of Figures ................................................................................................................................................................................. 2
       Section 1 - About the Company.......................................................................................................................................................... 4
       Chiesi Farmaceutici SpA - Key Facts ................................................................................................................................................. 4
       Chiesi Farmaceutici SpA - Key Employees ........................................................................................................................................ 5
       Chiesi Farmaceutici SpA - Key Operational Employees ..................................................................................................................... 6
       Chiesi Farmaceutici SpA - Major Products and Services ................................................................................................................... 7
       Chiesi Farmaceutici SpA - Pharmaceutical Pipeline Products Data ................................................................................................... 8
          Chiesi Farmaceutici SpA, Pipeline Products by Therapy Area ....................................................................................................... 8
          Chiesi Farmaceutici SpA, Pipeline Products by Development Phase ............................................................................................. 9
       Chiesi Farmaceutici SpA - History .................................................................................................................................................... 12
       Chiesi Farmaceutici SpA - Company Statement .............................................................................................................................. 14
       Chiesi Farmaceutici SpA - Locations And Subsidiaries .................................................................................................................... 15
          Head Office ................................................................................................................................................................................... 15
          Other Locations & Subsidiaries ..................................................................................................................................................... 15
       Section 2 – Company Analysis ......................................................................................................................................................... 16
       Chiesi Farmaceutici SpA - Business Description.............................................................................................................................. 16
       Chiesi Farmaceutici SpA - Corporate Strategy ................................................................................................................................. 17
       Chiesi Farmaceutici SpA - SWOT Analysis ...................................................................................................................................... 18
          SWOT Analysis - Overview........................................................................................................................................................... 18
          Chiesi Farmaceutici SpA - Strengths ............................................................................................................................................ 18
             Strength - Strong Product Portfolio ........................................................................................................................................... 18
             Strength - Widespread Global Presence ................................................................................................................................... 18
             Strength - Sturdy Research and Development Activities ........................................................................................................... 18
             Strength - Robust Manufacturing Capabilities ........................................................................................................................... 19
          Chiesi Farmaceutici SpA - Weaknesses ....................................................................................................................................... 19
             Weakness - Supply Chain ......................................................................................................................................................... 19
             Weakness - Locked-up Enterprise Value .................................................................................................................................. 19
          Chiesi Farmaceutici SpA - Opportunities ...................................................................................................................................... 19
             Opportunity - Strong Product Pipeline ....................................................................................................................................... 19
             Opportunity - Strategic Agreements .......................................................................................................................................... 20
             Opportunity - Market Prospects – CVD and Asthma ................................................................................................................. 20
          Chiesi Farmaceutici SpA - Threats ............................................................................................................................................... 20
             Threat - Failure of New Product in Clinical Trials ...................................................................................................................... 20
             Threat - Stringent Government Regulations .............................................................................................................................. 20
             Threat - Increased Pricing Control............................................................................................................................................. 21
       Chiesi Farmaceutici SpA - Key Competitors..
								
To top